These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23469594)

  • 21. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis.
    Leifeld L; Pfützer R; Morgenstern J; Gibson PR; Marakhouski Y; Greinwald R; Mueller R; Kruis W
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1115-22. PubMed ID: 21923715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on effect of four traditional Chinese medicines distributed along lung meridian on TLR2 and NF-κB expressions in mice with lung heat syndrome].
    Yang P; Jin SA; Che LJ; He SM; Yuan Y
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3359-62. PubMed ID: 25522628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acupuncture combined with medication for ulcerative colitis with damp-heat syndrome at active phase].
    Chen K; Li C
    Zhongguo Zhen Jiu; 2015 May; 35(5):435-8. PubMed ID: 26255512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.
    Sandborn WJ; Kamm MA; Lichtenstein GR; Lyne A; Butler T; Joseph RE
    Aliment Pharmacol Ther; 2007 Jul; 26(2):205-15. PubMed ID: 17593066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.
    Lichtenstein GR; Kamm MA; Sandborn WJ; Lyne A; Joseph RE
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1094-102. PubMed ID: 18363894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
    Sandborn WJ; Regula J; Feagan BG; Belousova E; Jojic N; Lukas M; Yacyshyn B; Krzeski P; Yeh CH; Messer CA; Hanauer SB
    Gastroenterology; 2009 Dec; 137(6):1934-43.e1-3. PubMed ID: 19766640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of functional dyspepsia by Chinese medical syndrome typing: a randomized control research].
    Fan YH; Cai LJ; Xu GP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Dec; 32(12):1592-7. PubMed ID: 23469593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Observation on curative effect of chronic ulcerative colitis treated by retention enema with combination of Chinese and Western drugs].
    Wang XY; Wu Y; Jiang XM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1123-5. PubMed ID: 18198649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study in treating intractable ulcerative colitis with traditional Chinese medicine].
    Chen ZS; Nie ZW; Sun QL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Jul; 14(7):400-2. PubMed ID: 7950223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on phytoestrogenic-like effects of four kinds of Chinese medicine including Radix Rehmanniae Preparata, Radix Paeoniae Alba, Radix Angelicae Sinensis, Rhizoma Chuanxiong].
    Hao Q; Wang J; Niu J; Zhao P; Cui Y; Sun L; Xue X
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):620-4. PubMed ID: 19526797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis.
    D'Haens G; Sandborn WJ; Barrett K; Hodgson I; Streck P
    Am J Gastroenterol; 2012 Jul; 107(7):1064-77. PubMed ID: 22565161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental study on treatment of immune ulcerative colitis in mice by Changlu Enema].
    Wu YN; Xiao YQ; Chen YB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jan; 27(1):65-8. PubMed ID: 17302068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: A randomized controlled trial.
    Dai YC; Zheng L; Zhang YL; Chen X; Chen DL; Tang ZP
    Medicine (Baltimore); 2017 Apr; 96(16):e6651. PubMed ID: 28422869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
    Lichtenstein GR; Kamm MA; Boddu P; Gubergrits N; Lyne A; Butler T; Lees K; Joseph RE; Sandborn WJ
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):95-102. PubMed ID: 17234558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
    Miner PB; Wedel MK; Xia S; Baker BF
    Aliment Pharmacol Ther; 2006 May; 23(10):1403-13. PubMed ID: 16669955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of ulcerative colitis by combined therapy of retention enema and per-colonoscopic spraying with zhikang capsule compound liquid].
    Zhang J; Zeng YF; Xiao BQ; Wang J; Zhao A
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Sep; 25(9):839-42. PubMed ID: 16248252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.
    Tursi A; Brandimarte G; Giorgetti GM; Forti G; Modeo ME; Gigliobianco A
    Med Sci Monit; 2004 Nov; 10(11):PI126-31. PubMed ID: 15507864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.